Product Information
ERYTHROMYCIN 500 MG TABLET is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $2.8197 per EA under NDC 52536010513. Its NADAC has been published 339 times since Nov 14, 2018.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536010513
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA061621FDA Approved
Before 1982
TE Code
AB
On Market Since
3/15/2018
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 500 MG TABLET has been published 339 times since Nov 14, 2018, and over the history we have for it it has declined 82.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8197 per EA |
|---|---|
| All-time high | $15.7744 (Dec 12, 2018) |
| All-time low | $2.0242 (Aug 21, 2024) |
| Median price | $13.2213 |
| Average price | $10.5755 |
| Largest weekly change | +40.9% (Nov 20, 2024) |
| Weeks tracked | 339 |
| Tracking since | Nov 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-68.6%
5Y
-78.7%
All
-82.1%
Last surveyed May 7, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 500 MG TABLET, manufactured by Wilshire Pharmaceuticals Inc., is $2.8197 per EA (NDC 52536010513), effective May 7, 2025.
How has the price of ERYTHROMYCIN 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 500 MG TABLET has declined 82.1%. It has been tracked across 339 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 500 MG TABLET?
Since Nov 14, 2018, the NADAC for ERYTHROMYCIN 500 MG TABLET has ranged from a low of $2.0242 (Aug 21, 2024) to a high of $15.7744 (Dec 12, 2018), with a median of $13.2213 per EA.
Are there cheaper alternatives to ERYTHROMYCIN 500 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 500 MG TABLET, is $2.5871 per EA — about 8% below ERYTHROMYCIN 500 MG TABLET.
Who manufactures ERYTHROMYCIN 500 MG TABLET?
ERYTHROMYCIN 500 MG TABLET (NDC 52536010513) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.